Clinical and research tests for C0020630 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 53

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
OI and Bone Fragility Gene Panel Mayo Clinic Laboratories Mayo Clinic United States	31	25	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Renal Stone/Electrolyte Gene Panel Mayo Clinic Laboratories Mayo Clinic United States	82	71	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Abnormal mineralization disorders Deletion/ Duplication Panel HNL Genomics Connective Tissue Gene Tests United States	2	15	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Abnormal mineralization disorders Comprehensive Panel HNL Genomics Connective Tissue Gene Tests United States	2	15	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Expanded Carrier Screening Genome-Nilou Lab Iran	110	146	C Sequence analysis of the entire coding region
Invitae Hypophosphatemia Panel Invitae United States	23	17	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hypophosphatasia, Autosomal Recessive Myriad Genetics, Inc. United States	1	1	C Sequence analysis of the entire coding region
Hypophosphatasia, infantile, childhood & adult types HNL Genomics Connective Tissue Gene Tests United States	4	1	C Sequence analysis of the entire coding region T Targeted variant analysis
Hypophosphatasia, infantile, childhood & adult types Comprehensive Test HNL Genomics Connective Tissue Gene Tests United States	4	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hypophosphatasia, infantile, childhood & adult types Deletion / Duplication Test HNL Genomics Connective Tissue Gene Tests United States	4	1	D Deletion/duplication analysis
Osteogenesis imperfecta NGS panel - Dominant & Recessive HNL Genomics Connective Tissue Gene Tests United States	30	24	C Sequence analysis of the entire coding region T Targeted variant analysis
Osteogenesis imperfecta Comprehensive panel - Recessive HNL Genomics Connective Tissue Gene Tests United States	23	19	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Osteogenesis imperfecta NGS panel - Recessive HNL Genomics Connective Tissue Gene Tests United States	23	19	C Sequence analysis of the entire coding region T Targeted variant analysis
Osteogenesis imperfecta Deletion / Duplication panel - Dominant & Recessive HNL Genomics Connective Tissue Gene Tests United States	30	24	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Osteogenesis imperfecta Deletion / Duplication panel - Recessive HNL Genomics Connective Tissue Gene Tests United States	23	19	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Osteogenesis imperfecta Comprehensive panel - Dominant & Recessive HNL Genomics Connective Tissue Gene Tests United States	30	24	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Abnormal mineralization disorders Deletion/ Duplication Panel HNL Genomics Connective Tissue Gene Tests United States	2	15	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Abnormal mineralization disorders Comprehensive Panel HNL Genomics Connective Tissue Gene Tests United States	2	15	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hypophosphatasia Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba Canada	1	1	T Targeted variant analysis
Targeted Variant Analysis Integrated Genetics Westborough LabCorp United States	330	746	T Targeted variant analysis

<< First< Prev

Page 1 of 3

Results: 1 to 20 of 53

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.